兰州大学机构库

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 study 期刊论文
JOURNAL OF VIRAL HEPATITIS, 2022, 卷号: 29, 期号: 6, 页码: 455-464
Authors:  Hua, Rui;  Kong, Fei;  Wen, Xiaofeng;  Xiong, Qingfang;  Chen, Jiayu;  Meng, Chenxin;  Ma, Hong;  Tan, Youwen;  Huang, Yan;  Jiang, Yongfang...Hua, Rui;  Kong, Fei;  Wen, Xiaofeng;  Xiong, Qingfang;  Chen, Jiayu;  Meng, Chenxin;  Ma, Hong;  Tan, Youwen;  Huang, Yan;  Jiang, Yongfang;  Guan, Yujuan;  Mao, Xiaorong;  Wang, Jiefei;  Xin, Yongning;  Gao, Hainv;  Xu, Bin;  Li, Cheng;  Wu, Qiong;  Zhang, Xian;  Wang, Zhiqiang;  Zhao, Liwen;  Zhang, Yuexin;  Li, Guangming;  Niu, Junqi
Favorite  |    Submit date:2022/07/01
alfosbuvir  China  daclatasvir  hepatitis C virus  pan-genotypic  
A phase 2, open-label study of pan-genotype regimen of SH229 plus daclatasvir in Chinese patients with chronic hepatitis C virus infection 会议论文
ELSEVIER
Authors:  Hua, Rui;  Kong, Fei;  Li, Guangming;  Zhang, Yuexin;  Wen, Xiaofeng;  Xiong, Qingfang;  Chen, Jiayu;  Meng, Chenxin;  Ma, Hong;  Tan, Youwen...Hua, Rui;  Kong, Fei;  Li, Guangming;  Zhang, Yuexin;  Wen, Xiaofeng;  Xiong, Qingfang;  Chen, Jiayu;  Meng, Chenxin;  Ma, Hong;  Tan, Youwen;  Huang, Yan;  Jiang, Yongfang;  Guan, Yujuan;  Mao, Xiaorong;  Wang, Jiefei;  Xin, Yongning;  Gao, Hainv;  Xu, Bin;  Li, Cheng;  Zhang, Xian;  Wang, Zhiqiang;  Ding, Yanhua;  Niu, Junqi
Favorite  |    Submit date:2023/12/04
SH229 plus daclatasvir for treatment of chronic hepatitis C virus infection in China: a single-arm, open-label, phase 3 study 会议论文
JOURNAL OF HEPATOLOGY
Authors:  Hua, Rui;  Kong, Fei;  Wen, Xiaofeng;  Yang, Xingxiang;  Meng, Chenxin;  Jiang, Yongfang;  Xie, Wen;  Wang, Xiaozhong;  Han, Xueji;  Huang, Yan...Hua, Rui;  Kong, Fei;  Wen, Xiaofeng;  Yang, Xingxiang;  Meng, Chenxin;  Jiang, Yongfang;  Xie, Wen;  Wang, Xiaozhong;  Han, Xueji;  Huang, Yan;  Wang, Jiefei;  Mao, Qing;  Guan, Yujuan;  Chen, Jiayu;  Ma, Yingjie;  Ma, Hong;  Xiong, Qingfang;  Yan, Xuebing;  Rao, Huiying;  Zhao, Yingren;  Sun, Tong;  Mao, Xiaorong;  Lian, Jianqi;  Zhu, Liying;  Xin, Yongning;  Deng, Guojiong;  Wang, Yifei;  Xu, Bin;  Gao, Hainv;  Tan, Youwen;  Ye, Yinong;  Li, Dongliang;  Yang, Dongliang;  Su, Minghua;  Li, Cheng;  Shen, Xian;  Wu, Qiong;  Zhang, Xian;  Wang, Zhiqiang;  Zhao, Liwen;  Zhang, Yuexin;  Li, Guangming;  Niu, Junqi
Favorite  |    Submit date:2021/08/13
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China 期刊论文
Infectious Diseases and Therapy, 2023
Authors:  Hua, Rui;  Kong, Fei;  Li, Guangming;  Wen, Xiaofeng;  Zhang, Yuexin;  Yang, Xingxiang;  Meng, Chenxin;  Xie, Wen;  Jiang, Yongfang;  Wang, Xiaozhong...Hua, Rui;  Kong, Fei;  Li, Guangming;  Wen, Xiaofeng;  Zhang, Yuexin;  Yang, Xingxiang;  Meng, Chenxin;  Xie, Wen;  Jiang, Yongfang;  Wang, Xiaozhong;  Han, Xueji;  Huang, Yan;  Mao, Qing;  Wang, Jiefei;  Guan, Yujuan;  Chen, Jiayu;  Ma, Yingjie;  Xiong, Qingfang;  Ma, Hong;  Yan, Xuebing;  Rao, Huiying;  Zhao, Yingren;  Sun, Tong;  Zhu, Liying;  Mao, Xiaorong;  Lian, Jianqi;  Deng, Guojiong;  Xin, Yongning;  Wang, Yifei;  Ye, Yinong;  Xu, Bin;  Gao, Hainv;  Tan, Youwen;  Li, Dongliang;  Yang, Dongliang;  Su, Minghua;  Zhang, Xiaomeng;  Min, Jie;  Shi, Xinsheng;  Wei, Lai;  Niu, Junqi
Favorite  |    Submit date:2023/11/28
Alfosbuvir  Daclatasvir  Hepatitis C virus  China